Could a machine hold the key to ending one of humanity’s most persistent health crises? At Scripps Research, a staggering $1.1 million investment in artificial intelligence (AI) is igniting a new chapter in the fight against HIV, a virus that continues to impact over 40 million people worldwide.
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with a wealth of experience in research and development, as well as a keen understanding of technological innovation in the industry. Today, we’re diving into the recent developments surrounding Agios Pharmaceuticals and their
In a groundbreaking development for rheumatoid arthritis treatment, Lifordi Immunotherapeutics, a clinical-stage biotech firm headquartered in Burlington, Massachusetts, has successfully raised $112 million in a funding round led by Sanofi Ventures, with continued support from prominent investors
Spinal Muscular Atrophy (SMA), a rare genetic disorder that causes progressive muscle weakness and significant life challenges, has long been a focus of medical research seeking transformative solutions for affected individuals across all ages. A pivotal moment in this journey arrived on November
What lies at the heart of life’s intricate design, shaping everything from a single cell to the complex tissues of the human body? The answer may surprise many: it’s not just the cells themselves, but the unseen network surrounding them, known as the extracellular matrix (ECM). This dynamic web of
In a world where breast cancer claims countless lives each year, a staggering statistic emerges: over 70% of cases are estrogen receptor-positive (ER+), making them particularly challenging to treat due to their ability to adapt and resist therapies. Imagine a microscopic battlefield within the
